A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Google and Universal Music might license artists' voices for AI-generated music
Virginia finalizes guidance on transgender students, including rolling back some accomodations
Katy Perry responds to viral video of her at King Charles III's coronation
At Toronto tech show, second thoughts emerge over AI
Earnings Are the Tech-Stock Rally’s Next Big Test
Federal complaint challenges Harvard legacy admissions
MoviePass Returns With $10/Month Plan
What happened to Kai Cenat? Twitch king in hot water after he unintentionally shows firearm during livestream